CIK 1687078
MPM BioImpact LLC
Institutional 13F holdings & portfolio
Holdings
38
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
3
Holdings
13F filings as of Dec 31, 2025 · Showing 1–38 of 38
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 7.6M | $1M+ | SH |
| MDGL | Madrigal Pharmaceuticals Inc | 97K | $1M+ | SH |
| LQDA | Liquidia Corp | 1.4M | $1M+ | SH |
| TRVI | Trevi Therapeutics Inc | 3.3M | $1M+ | SH |
| EWTX | Edgewise Therapeutics Inc | 1.7M | $1M+ | SH |
| RVMD | Revolution Medicines, Inc. | 506K | $1M+ | SH |
| AGIO | Agios Pharmaceuticals Inc | 1.3M | $1M+ | SH |
| QURE | Uniqure NV | 1.4M | $1M+ | SH |
| PTCT | PTC Therapeutics Inc | 430K | $1M+ | SH |
| SNDX | Syndax Pharmaceuticals Inc | 1.3M | $1M+ | SH |
| DYN | Dyne Therapeutics, Inc. | 1.4M | $1M+ | SH |
| TARS | Tarsus Pharmaceuticals Inc | 329K | $1M+ | SH |
| STOK | Stoke Therapeutics Inc | 770K | $1M+ | SH |
| ALMS | Alumis Inc | 2.4M | $1M+ | SH |
| URGN | Urogen Pharma Ltd | 941K | $1M+ | SH |
| XENE | Xenon Pharmaceuticals Inc | 486K | $1M+ | SH |
| PVLA | Palvella Therapeutics Inc | 206K | $1M+ | SH |
| NTRA | Natera Inc | 94K | $1M+ | SH |
| CRVS | Corvus Pharmaceuticals Inc | 2.7M | $1M+ | SH |
| DBVT | DBV Technologies S A | 997K | $1M+ | SH |
| RLAY | Relay Therapeutics Inc. | 2.2M | $1M+ | SH |
| GLUE | Monte Rosa Therapeutics Inc | 1.2M | $1M+ | SH |
| DRUG | Bright Minds Biosciences Inc | 230K | $1M+ | SH |
| PTGX | Protagonist Therapeutics Inc | 199K | $1M+ | SH |
| ENGN | enGene Holdings, Inc. | 1.8M | $1M+ | SH |
| CNTX | Context Therapeutics Inc | 10.7M | $1M+ | SH |
| ARQT | Arcutis Biotherapeutics Inc | 531K | $1M+ | SH |
| VTYX | Ventyx Biosciences Inc | 1.6M | $1M+ | SH |
| ORIC | Oric Pharmaceuticals Inc | 1.8M | $1M+ | SH |
| BLTE | Belite Bio Inc | 88K | $1M+ | SH |
| RAPT | RAPT Therapeutics Inc | 398K | $1M+ | SH |
| CLYM | Climb Bio Inc | 2.7M | $1M+ | SH |
| ABVX | Abivax SA | 56K | $1M+ | SH |
| RCKT | Rocket Pharmaceuticals, Inc. | 1.6M | $1M+ | SH |
| MAZE | Maze Therapeutics Inc | 81K | $1M+ | SH |
| EVMN | Evommune Inc | 113K | $1M+ | SH |
| SRPT | Sarepta Therapeutics Inc | 70K | $1M+ | SH |
| HOWL | Werewolf Therapeutics, Inc. | 1.4M | $500K+ | SH |